Correction to “TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway”
2017 ◽
Vol 364
(1)
◽
pp. 26-27
2014 ◽
Vol 351
(2)
◽
pp. 352-358
◽
2005 ◽
Vol 25
(2)
◽
pp. 329-335
◽
2006 ◽
Vol 119
(7)
◽
pp. 1751-1752
◽
Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer
2010 ◽
Vol 37
(1)
◽
pp. 183-193
◽
2018 ◽
Vol 131
(8)
◽
pp. 1005-1006
◽